Contact Us

Contact us for support.

Click Here

Hepatitis B

Hepatitis B is treatable and preventable. How?

Click Here


Answers to some tough questions about hepatitis B.

Click Here

Lack of political will by gov’t hampering fight against hepatitis

The President of the Theobald Hepatitis B Foundation in Ghana, Mr. Theobald Owusu Ansah, has hinted that government is not doing enough in dealing with hepatitis B in the country. He said government ought to give attention to hepatitis as it does HIV but unfortunately, that is not happening. Mr. Owusu-Ansah, who was speaking to […]

Genetic driver of inflammation uncovered, used to prevent and treat liver cancer

Inflammation has been shown to be a driving force behind many chronic diseases, especially liver cancer, which often develops due to chronic inflammation caused by conditions such as viral hepatitis or alcoholism and has relatively few effective treatment options. Now, scientists at Virginia Commonwealth University Massey Cancer Center have demonstrated for the first time in […]

Increase seen in liver injury caused by herbals, dietary supplements

New research shows that liver injury caused by herbals and dietary supplements increased from 7% to 20% in a U.S. study group over a ten-year period. According to the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, liver injury caused by non-bodybuilding supplements is most severe, occurring […]

Recommendations to Improve Liver Health in Hepatitis B, Hepatitis C Patients

Although it is widely understood that hepatitis B virus (HBV) and hepatitis C virus (HCV) are the leading causes of liver cirrhosis and liver cancer, a study published in Cancer Nursing reports an alarming number of HBV and HCV carriers have unhealthy habits that result in poor liver health. To learn about the behavior and […]

Hepatitis B: Screening of 30 Boxers at Bukom

The Theobald Hepatitis B Foundation and Hepatitis Coalition of Ghana on Friday, September 12, 2014 screened 30 boxers at Bukom. The President of the Foundation and Coalition, Mr. Theobald Owusu-Ansah educated the boxers on the nature of the disease before the screening. He told the boxers that being infected with Hepatitis B was not a […]

Novira completes Phase 1a clinical study of NVR-1221 for treatment of HBV infection

Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announced successful completion of a Phase 1a clinical study of NVR-1221. The results for the Phase 1a clinical study demonstrated NVR-1221 was safe and well-tolerated at all doses in 40 healthy volunteers. The […]

Sudan: Hepatitis Outbreak Kills 150 People in South Darfur’s Kalma IDP Camp

Khartoum — An outbreak of hepatitis at Kalma camp for Internally Displaced People in South Darfur state has led to the death of 150 people and infected 500 others. Hepatitis, an inflammation of the liver, is commonly caused by viral infection. According to the WHO, hepatitis E is included amongst the most concerning iterations of […]

Research and Markets: Global Hepatitis B Vaccines Market 2014-2018 – GlaxoSmithKline, Merck & Sanofi Pasteur Dominate the Market

DUBLIN — Research and Markets ( has announced the addition of the “Global Hepatitis B Vaccines Market 2014-2018″ report to their offering. The Global Hepatitis B Vaccines market to grow at a CAGR of 4.00 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Hepatitis B […]

Hepatitis E cases on the rise in Lakes state

September 6, 14 (JUBA) – Cases of Hepatitis E is on the rise in South Sudan’s Lakes state, with about 100 people diagnosed with the disease, the United Nations humanitarian coordination agency (OCHA) said. Two cases of the disease, OCHA said, were initially recorded in April and 52 in June. At least four people have […]

Gilead Close to Sending $84,000 Drug to Poor Countries

Gilead Sciences Inc. (GILD:US) is close to a pact with generic drugmakers to bring low-cost versions of its $84,000 hepatitis C drug Sovaldi to about 80 developing countries including India, Indonesia, and Pakistan. The broad licensing deal could be completed as soon as mid-September and would allow the generic manufacturers to produce Sovaldi and an […]